Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
IMRICOR MEDICAL SYSTEMS INC (IMR)ASX AI Signals has generated 3 signal for IMR during the last 90 days, indicating active trading activity and ongoing AI monitoring
Latest IMR Signals | |
| 11/06/2026 | SELL |
| 16/04/2026 | BUY |
| 10/04/2026 | SELL |
IMR Share Price | |
| Current Price | $1.990 |
| 52 Week High | $2.200 |
| 52 Week Low: | $1.195 |
| Trading at (% of 52 Week High) | 90.45% |
Imricor Medical Systems Inc (ASX: IMR) develops and sells medical devices for cardiac magnetic resonance imaging (MRI)-guided procedures. The company's products help improve the precision and safety of heart treatments by combining MRI technology with catheter-based interventions. Imricor focuses on advancing minimally invasive cardiac care.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The SELL recommendation for IMRICOR MEDICAL SYSTEMS INC is supported by moderate bearish signals, including recent price weakness and potential sector headwinds. However, the relatively low liquidity and limited market capitalization introduce uncertainty, tempering confidence.
MINNEAPOLIS, January 25, 2023--(BUSINESS WIRE)--Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with GE HealthCare.
Insiders who purchased US$201k worth of Imricor Medical Systems, Inc. (ASX:IMR) shares over the past year recouped some of their losses after price gained 75% last week. The purchase, however, has proven to be a pricey bet, with losses currently totalling US$42k.
While insider transactions are not Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done If you want to know who really controls Imricor Medical Systems, Inc. (ASX:IMR), then you'll have to look at the makeup of its share registry. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. I quite like to see at least Latest IMRICOR MEDICAL SYSTEMS INC(IMR) News
Imricor Collaborates with GE HealthCare in Interventional Cardiac MRI
Insiders purchases in Imricor Medical Systems, Inc. (ASX:IMR) last year yet to pay off, remain down US$42k despite recent gains
Is Imricor Medical Systems (ASX:IMR) In A Good Position To Invest In Growth?
How Much Of Imricor Medical Systems, Inc. (ASX:IMR) Do Insiders Own?
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial